Hsbc Holdings PLC Ginkgo Bioworks Holdings, Inc. Transaction History

Hsbc Holdings PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.28 - $1.16 $9,516 - $39,423	33,986 Added 56.04%	94,630 $31,000
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $5,400 - $8,508	-5,095 Reduced 7.75%	60,644 $70,000
Q4 2023 Feb 12, 2024	SELL	$1.26 - $1.79 $813 - $1,156	-646 Reduced 0.97%	65,739 $111,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $22,348 - $35,257	13,881 Added 26.44%	66,385 $120,000
Q2 2023 Aug 11, 2023	SELL	$1.14 - $1.95 $120,643 - $206,364	-105,828 Reduced 66.84%	52,504 $97,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $65,113 - $118,831	54,261 Added 52.14%	158,332 $210,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $979 - $2,115	601 Added 0.58%	104,071 $175,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $35,740 - $183,110	48,960 Added 89.82%	103,470 $326,000
Q2 2022 Aug 11, 2022	BUY	$2.2 - $4.2 $76,672 - $146,374	34,851 Added 177.28%	54,510 $132,000
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $163,366 - $293,312	19,659 New	19,659 $163,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.